[Ip-health] Boseley in the Guardian "Could trade rules spell the end of lifesaving cheap AIDS drugs?"
Riaz K Tayob
riaz.tayob at gmail.com
Wed Sep 22 02:59:55 PDT 2010
Does anyone have info on HIV Res. net the process through which
countries share suspected resistant virus blood samples through national
working groups and then finally with WHO? How do companies get access to
this and is there any control over the intellectual property rights...
or is this just another South to North free donation?
On 2010/09/20 05:01 PM, Alexandra.LEE at geneva.msf.org wrote:
> Could trade rules spell the end of lifesaving cheap AIDS drugs?
> A new report shows that the vast majority of Aids drugs keeping people
> alive in poor countries are made by Indian generics companies, but new
> trade rules may prevent them making cheap copies in years to come
> Sarah Bosely
More information about the Ip-health